title: Casein kinase iδ mutations in familial migraine and advanced sleep phase.
abstract: Migraine is a common disabling disorder with a significant genetic component, characterized by severe headache and often accompanied by nausea, vomiting, and light sensitivity. We identified two families, each with a distinct missense mutation in the gene encoding casein kinase Iδ (CKIδ), in which the mutation cosegregated with both the presence of migraine and advanced sleep phase. The resulting alterations (T44A and H46R) occurred in the conserved catalytic domain of CKIδ, where they caused reduced enzyme activity. Mice engineered to carry the CKIδ-T44A allele were more sensitive to pain after treatment with the migraine trigger nitroglycerin. CKIδ-T44A mice also exhibited a reduced threshold for cortical spreading depression (believed to be the physiological analog of migraine aura) and greater arterial dilation during cortical spreading depression. Astrocytes from CKIδ-T44A mice showed increased spontaneous and evoked calcium signaling. These genetic, cellular, physiological, and behavioral analyses suggest that decreases in CKIδ activity can contribute to the pathogenesis of migraine.
authors: Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
authors: K C
authors: KC
authors: Brennan
authors: Emily A
authors: EA
authors: Bates
authors: Robert E
authors: RE
authors: Shapiro
authors: Jekaterina
authors: J
authors: Zyuzin
authors: William C
authors: WC
authors: Hallows
authors: Yong
authors: Y
authors: Huang
authors: Hsien-Yang
authors: HY
authors: Lee
authors: Christopher R
authors: CR
authors: Jones
authors: Ying-Hui
authors: YH
authors: Fu
authors: Andrew C
authors: AC
authors: Charles
authors: Louis J
authors: LJ
authors: Ptáček
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D020013:Calcium Signaling; D048148:Casein Kinase Idelta / Q000235:genetics* / Q000378:metabolism; D013181:Cortical Spreading Depression; D005260:Female; D057809:HEK293 Cells; D006801:Humans; D006930:Hyperalgesia / Q000235:genetics; D008297:Male; D051379:Mice; D008881:Migraine Disorders / Q000235:genetics* / Q000503:physiopathology; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D005996:Nitroglycerin; D010375:Pedigree; D010641:Phenotype; D010812:Physical Stimulation; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D012684:Sensory Thresholds; D012890:Sleep / Q000235:genetics*; D012894:Sleep Stages / Q000235:genetics; D013116:Spinal Cord / Q000378:metabolism / Q000473:pathology; D014278:Trigeminal Nuclei / Q000378:metabolism / Q000503:physiopathology; D014661:Vasoconstriction; D014664:Vasodilation
chemical_list: D050505:Mutant Proteins; D016760:Proto-Oncogene Proteins c-fos; D048148:Casein Kinase Idelta; D005996:Nitroglycerin
references: Cephalalgia. 2010 Feb;30(2):170-8
references: 19489890
references: Nature. 2005 Mar 31;434(7033):640-4
references: 15800623
references: J Neurosci. 2003 Feb 1;23(3):766-76
references: 12574405
references: Nature. 2010 Nov 11;468(7321):232-43
references: 21068832
references: Cephalalgia. 2007 Mar;27(3):193-210
references: 17381554
references: Am J Physiol Cell Physiol. 2006 Dec;291(6):C1193-7
references: 16885395
references: Neuron. 2004 Mar 4;41(5):701-10
references: 15003170
references: PLoS Genet. 2011 Jun;7(6):e1002129
references: 21731499
references: Cephalalgia. 2008 Nov;28(11):1170-8
references: 18644028
references: Nat Med. 2010 Oct;16(10):1157-60
references: 20871611
references: J Neurophysiol. 2007 Jun;97(6):4143-51
references: 17329631
references: Neurology. 2006 Jul 25;67(2):246-51
references: 16864816
references: J Neurosci. 2003 May 1;23(9):3588-96
references: 12736329
references: Nat Genet. 2003 Feb;33(2):192-6
references: 12539047
references: Ann Neurol. 2008 Sep;64(3):315-24
references: 18825664
references: Ann Neurol. 2004 Jan;55(1):19-26
references: 14705108
references: Cephalalgia. 1999 Sep;19(7):660-7; discussion 626
references: 10524660
references: Nat Genet. 2010 Oct;42(10):869-73
references: 20802479
references: J Neurosci. 2010 Jun 30;30(26):8807-14
references: 20592202
references: Nat Med. 2002 Feb;8(2):136-42
references: 11821897
references: Nat Genet. 2012 Jun 10;44(7):777-82
references: 22683712
references: Ann Neurol. 2007 Jun;61(6):603-6
references: 17474110
references: Brain. 2010 Apr;133(Pt 4):996-1012
references: 20348134
references: Lancet. 2005 Jul 30-Aug 5;366(9483):371-7
references: 16054936
references: Cell Signal. 2005 Jun;17(6):675-89
references: 15722192
references: J Neurosci. 2003 Oct 29;23(30):9888-96
references: 14586018
references: J Am Pharm Assoc Am Pharm Assoc. 1957 Mar;46(3):208-9
references: 13502156
references: Ann Neurol. 2006 Apr;59(4):652-61
references: 16450381
references: J Neurosci Methods. 1994 Jul;53(1):55-63
references: 7990513
references: Cephalalgia. 1993 Aug;13(4):245-8
references: 8374938
references: Cell. 1996 Nov 1;87(3):543-52
references: 8898206
references: J Biol Chem. 2002 Nov 22;277(47):44962-8
references: 12270943
references: J Biol Chem. 2002 Mar 22;277(12):10482-8
references: 11790776
references: Neuroscience. 1999;90(4):1371-6
references: 10338304
references: Pain. 1988 Jan;32(1):77-88
references: 3340425
references: Ann Neurol. 1997 Feb;41(2):166-72
references: 9029065
references: J Neurosci. 1998 Sep 15;18(18):7189-99
references: 9736642
references: Headache. 2010 Jun;50(6):955-62
references: 20412323
references: J Clin Invest. 2009 Jan;119(1):99-109
references: 19104150
references: J Neurosci. 2007 Apr 11;27(15):4036-44
references: 17428981
references: Nat Genet. 2011 Jun 12;43(7):695-8
references: 21666692
references: Cephalalgia. 2004;24 Suppl 1:9-160
references: 14979299
references: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9840-5
references: 12097649
references: Brain Res. 2001 Jul 13;907(1-2):117-24
references: 11430892
references: Semin Neurol. 2009 Sep;29(4):406-18
references: 19742415
references: Cephalalgia. 2011 Apr;31(6):737-47
references: 21335366
references: Ann Neurol. 2008 Feb;63(2):148-58
references: 18059010